文献速递痛风与晶体性关节病

痛风患者的全因死亡率与特定原因死亡率:系统综述与荟萃分析

All-cause and specific mortality in patients with gout: A systematic review and meta-analysis.
PubMed 文献 · Semin Arthritis Rheum · 2023-10-07

本荟萃分析纳入11项队列研究(2010-2022年),覆盖14,854,490人,随访1.66-16年,评估痛风与死亡风险的关系。结果显示痛风患者全因死亡率(HR=1.23,95%CI 1.13-1.35)、心血管死亡率(HR=1.29,95%CI 1.13-1.48)、感染死亡率(HR=1.24,95%CI 1.04-1.47)和消化系统疾病死亡率(HR=1.42,95%CI 1.13-1.80)均升高。

要点

  • 痛风患者全因死亡风险升高(HR=1.23,95%CI 1.13-1.35)。
  • 痛风患者心血管死亡风险升高(HR=1.29,95%CI 1.13-1.48)。
  • 痛风患者感染和消化系统疾病死亡风险亦升高。

核心结论

  • 痛风与全因死亡率、心血管疾病死亡率、感染死亡率和消化系统疾病死亡率升高相关。

研究设计与样本

  • 系统综述与荟萃分析,检索PubMed、EMBASE和Cochrane Library数据库自建库至2022年9月的已发表队列研究,纳入11项队列研究(2010-2022年),覆盖14,854,490人,随访1.66-16年,采用NOS量表评价研究质量,使用STATA软件(版本16.0)进行统计分析。

主要发现

  • 痛风患者全因死亡率升高(HR=1.23,95%CI 1.13-1.35,I²=96.4%,P<0.001)。
  • 痛风患者心血管死亡率升高(HR=1.29,95%CI 1.13-1.48,I²=98.5%,P<0.001)。
  • 痛风患者感染死亡率升高(HR=1.24,95%CI 1.04-1.47,I²=88.5%,P=0.019)。
  • 痛风患者消化系统疾病死亡率升高(HR=1.42,95%CI 1.13-1.80,I²=91.7%,P=0.003)。
  • 敏感性分析和亚组分析支持上述发现,未发现明显发表偏倚。

临床怎么用

  • 原文指出该发现对临床实践、痛风患者护理以及生活方式调整指导具有重要意义,以预防心血管事件、感染和消化系统疾病等不良结局。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: This meta-analysis aims to examine the general mortality risk and specific mortality risk of gout, as the incidence of the condition is on the rise but information on mortality rates remains uncertain. METHOD: The researchers conducted a search of published cohort studies on gout and mortality using Medical subject headings and keywords in PubMed, EMBASE, and Cochrane Library databases from inception to September 2022. The quality of study was evaluated using the NOS scale. Statistical analysis was performed using STATA software (version 16.0). Publication bias was assessed using funnel plots and Egger's test. RESULT: This meta-analysis included 11 cohort studies (2010-2022), covering 14,854,490 people with a follow-up time of 1.66-16 years. The pooled analysis shows increased risk of overall mortality [HR=1.23, 95 % CI (1.13-1.35), I2=96.4 %, P<0.001], cardiovascular mortality [HR=1.29, 95 % CI (1.13-1.48), I2=98.5 %, P<0.001], infection mortality [HR=1.24, 95 % CI (1.04-1.47), I2=88.5 %, P = 0.019], and digestive system disease mortality [HR=1.42, 95 % CI (1.13-1.80), I2=91.7 %, P = 0.003] in gout. Sensitivity and subgroup analysis support the findings, and publication bias was not evident. CONCLUSION: The findings from our meta-analysis indicate that gout is associated with an increased risk of all-cause mortality, as well as mortality related to cardiovascular disease, infections, and digestive system diseases. This has important implications for clinical practice, nursing care of patients with gout, and guidance on lifestyle modifications to prevent adverse outcomes such as cardiovascular events, infections, and digestive disorders.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Wang X, Li X, Wang H, et al. All-cause and specific mortality in patients with gout: A systematic review and meta-analysis. Semin Arthritis Rheum. 2023. PMID: 37832433. doi:10.1016/j.semarthrit.2023.152273

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。